SLC2A1 and acute myeloid leukemia: If GLUT1-overexpressed HSCs can compete for glucose against blasts while regenerating the healthy blood and immune systems of AML patients, then that could further elevate the likelihood of success for an already established and effective leukemic treatment option in the allogeneic HSC transplantation.